✦ LIBER ✦

Immunosuppressive requirements and liver function during pregnancy in liver transplant recipients: A single center experience

✍ Scribed by S.K.P. Cauduro; E. Hay

Book ID: 117372429
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 171 KB
Volume: 38
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(03)80522-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sirolimus in Liver Transplant Recipients

Sirolimus in Liver Transplant Recipients: A Large Single-Center Experience

✍ M. Vivarelli; A. Dazzi; A. Cucchetti; A. Gasbarrini; M. Zanello; P. Di Gioia; G. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Immunosuppression strategies after liver

Immunosuppression strategies after liver transplantation: a single centre experience in 57 liver transplant recipients

✍ Rajeev Sharma; M. R. Rajasekar; Arun Raghuvanshi 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 61 KB

Portocaval hemitransposition in pediatri

Portocaval hemitransposition in pediatric liver transplant recipients: A single-center experience

✍ Gerald S. Lipshutz; Supriya Patel; Jonathan R. Hiatt; Hassan Yersiz; Douglas G. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Few studies have reported a series of patients who have undergone portocaval hemitransposition at the time of orthotopic liver transplantation (OLT). Furthermore, no series report the outcome of pediatric patients who required the procedure. This work analyzes the experience with portocaval hemitran

Mycophenolate mofetil monotherapy in liv

Mycophenolate mofetil monotherapy in liver transplant recipients: A single center experience

✍ Kyrsten D. Fairbanks; Paul J. Thuluvath 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

The long-term use of calcineurin inhibitors (CIs) is associated with significant morbidity in liver transplant recipients. Although mycophenolate mofetil (MMF) is well tolerated, two small studies reported an unacceptable rate of acute allograft rejection in liver transplant recipients receiving MMF

Immunosuppression With Low-Dose Daclizum

Immunosuppression With Low-Dose Daclizumab in Liver Transplant Recipients With Impaired Kidney Function: A Single-Center Experience

✍ M. Post; J. Raszeja-Wyszomirska; K. Jarosz; J. Lubikowski; M. Wasilewicz; M. Myd 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Pregnancy outcome after liver transplant

Pregnancy outcome after liver transplantation: A single-center experience of 71 pregnancies in 45 recipients

✍ Vimala Christopher; Thawab Al-Chalabi; Paul D. Richardson; Paolo Muiesan; Mohamm 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

Infertility is common in women with end-stage liver disease. Successful liver transplant (LT), however, can restore childbearing potential. Controversy exists regarding the most appropriate immunosuppressive regimen and timing of conception following LT. We report the outcomes of a review of all pre